MedDataX Logo

Effect of Sinovac on Survival in Intensive Care Unit

NCT ID: NCT04956562

Last Updated: 2021-07-09

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

96 participants

Study Classification

OBSERVATIONAL

Study Start Date

2021-04-01

Study Completion Date

2021-05-15

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Effect of Inactivated COVID-19 Vaccine (Sinovac) on survival in intensive care unit, Single Center Experience

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Effect of Favipiravir on Mortality in Patients With COVID-19 at a Tertiary Center Intensive Care Unit

NCT04645433

Mortality Intensive Care Unit
COMPLETED

Consequences in ICU of Vaccination Status of Covid-19 Patients

NCT06191341

SARS CoV 2 Infection
COMPLETED

Study on ICU Patients With Nosocomial Lower Respiratory Tract Infections

NCT03183921

Pneumonia
UNKNOWN

EFFECTS OF EXTRACORPOREAL CYTOKINE ELIMINATION ON HEMODYNAMIA AND MORTALITY IN CRITICAL PATIENTS

NCT05984407

Cytokine Hemadsorption Therapy in Critically Ill Patients Who Have no Microbiological Findings and Develop Vasoplegic Shock
UNKNOWN

Factors Affecting Mortality in Critical Patients Admitted to Intensive Care Unit Due to Coronavirus Disease 2019

NCT04659876

Covid19 and Mortality
COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Turkey has started vaccinate healthcare professionals at 13 January 2021 by Sinovac vaccine and declared a step by step inclusion schedule The primary aim of the study is to compare clinical, laboratory and survival data of COVID-19 patients who were vaccinated at least 14 days before enrollment to the study with COVID-19 patients not vaccinated although they would have. The secondary aim is to compare age of enrolled patients to ICU due to SARS-CoV-2 infection with patients admitted to ICU before start of vaccination program.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Survival Intensive Care Unit

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Vaccinated with sinovac

Vaccinated COVID-19 patients over 65 years consisted the study group

No interventions assigned to this group

Unvaccinated

Unvaccinated patients over 65 years composed the control group

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients with covid 19 over the age of 65 who were admitted to the intensive care unit between 1 April 2021 and 15 May 2021

Exclusion Criteria

* admissions to ICU due to reasons other than COVID-19, age younger than 65, continued admission at the end of enrolment date,
Minimum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Sisli Hamidiye Etfal Training and Research Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Sultan Acar Sevinç

consultant doctor

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Sisli Hamidiye Etfal Research and Training Hospital

Istanbul, , Turkey (Türkiye)

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

References

Explore related publications, articles, or registry entries linked to this study.

Sevinc SA, Metin S, Basi NB, Ling J, Cinar AS, Oba S. Effectiveness of inactivated SARS-CoV-2 vaccine (CoronaVac) on intensive care unit survival. Epidemiol Infect. 2022 Feb 9;150:e35. doi: 10.1017/S0950268822000267.

Reference Type DERIVED
PMID: 35135644 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

1903

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Effectiveness of Convalescent Immune Plasma Therapy
NCT04442958 COMPLETED NA
Sepsis Metabolomics
NCT01649440 COMPLETED
Evaluation of Immunonutrition For Patients With Pneumonia in the Intensive Care Unit.
NCT05463458 UNKNOWN NA
Risk Factors for Mortality for COVID-19 Admitted to an Intensive Care Unit
NCT04805645 TERMINATED
Epidemiology and Determinants of Outcomes of Hospital Acquired Blood Stream Infections in the Intensive Care in Turkey
NCT04304456 UNKNOWN
Evaluation of Enteral Nutrition in Critically Ill Children
NCT04013893 UNKNOWN
Comparison of the Results of Bronchoalveolar Lavage Culture and Endotracheal Aspirate Culture in Intubated Critically Ill COVID-19 Patients
NCT05403489 COMPLETED
Predictors of Respiratory Failure in SARS-Cov-2 Infection
NCT04316949 UNKNOWN
Sepsis in ICU:Causes and Outcomes of Sepsis in Diabetics Versus Non Diabetics in Assiut University Hospital
NCT04015752 UNKNOWN
Effectiveness of the Cytokine Hemadsorption on Sepsis
NCT05057455 COMPLETED
Clinical Application of Cytokine Adsorption Technique in AIDS Patients With Severe Pneumonia and/or Septic Shock
NCT06145828 RECRUITING
Thromboembolic Complications in COVID-19 Patients in Intensive Care Unit
NCT06037707 COMPLETED
Assessment of Clinical Effects of Coenzyme Q10 Levels in COVID-19 Patients in Intensive Care Unit
NCT05058716 UNKNOWN
Sepsis in Respiratory Intensive Care Unit
NCT05240157 COMPLETED
Clinical Characteristics, Outcomes and Risk Factors for Mortality in Pregnant/Puerperal Women With COVID-19 Admitted to ICU in Turkey: a Multicenter, Retrospective Study From a Middle-income Country.
NCT05930340 COMPLETED
Early Versus Delayed Enteral Nutrition in Critically Ill Adults With COVID-19
NCT06134674 COMPLETED
Impact of Respiratory Virus in Critically Ill Patients With Acute Respiratory Failure
NCT04411368 UNKNOWN
Investigation of The Prevalence of Sepsis in Adults in Multicenter Intensive Care Unıts in Turkey
NCT03179189 UNKNOWN
Severe Pandemic H1N1 Infection in ICU: Comparative Resource Utilization
NCT01485237 COMPLETED
Anti-pyretic Therapy in Critically Ill Adults
NCT01173367 COMPLETED PHASE2
Thrombosis Risk Assessment and Clinical Presentation of Covid-19 Pneumonia
NCT04423315 COMPLETED
Optimizing Stress Ulcer Prophylaxis Practices and Reducing Associated Costs in Intensive Care Units: a Nonrandomized Controlled Study
NCT06586333 COMPLETED NA
Sepsis in ICU:Causes and Outcomes in Diabetics and Non Diabetics
NCT05914480 UNKNOWN
Incidence Of Hepatitis In Intensive Care Unit
NCT03456037 UNKNOWN
Effect of Metabolic Dysfunction in Branched-chain Amino Acids on Cardiac Function in Patients With Sepsis
NCT06258252 NOT_YET_RECRUITING